The initiation of coverage by UBS with a Neutral rating suggests that the stock is fairly valued at current levels. The price target of $87 indicates where UBS believes the stock will trade in the near future. This news is highly relevant to OTIS as it directly pertains to the company's stock. The importance is moderate as analyst ratings can influence investor sentiment and stock price. The confidence in this analysis is high as the information is clear and direct.